Gero AI is a therapeutics company focused on rewriting human aging by applying physics-informed artificial intelligence to understand and intervene in aging processes. The company leverages a large, longitudinal clinical dataset and real-world health information to map aging trajectories, identify causal pathways, and drive development of drugs that restore systemic resilience and delay age-related diseases. Its platform combines theoretical physics, biology, and AI to differentiate irreversible aging from reversible disease processes with the goal of doubling healthy lifespan within a generation. Gero collaborates with pharmaceutical partners while pursuing in-house anti-aging research and platform-based discoveries on a global scale.
No recent news for this company.
No recent deals for this company.